Kadant (KAI) will replace Inari Medical (NARI) in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, February 19.
In a report released today, Gary Prestopino from Barrington maintained a Buy rating on Kadant (KAI – Research Report), with a price target of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback